1. Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of respiratory distress syndrome-2016 update. Neonatology 2017; 111(2): 107–125.
2.
Negi R, Pande D, Karki K, et al. A novel approach to study oxidative stress in neonatal respiratory distress syndrome. BBA Clinical 2015; 3: 65–69.
3.
Cheeseman K, Slater T. An introduction to free radical biochemistry. Br Med Bull 1993; 49(3): 481–493.
4.
Lee J, Giordano S, Zhang J. Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem J 2012; 441(2): 523–540.
5.
Negi R, Pande D, Kumar A, et al. In vivo oxidative DNA damage and lipid peroxidation as a biomarker of oxidative stress in preterm low-birthweight infants. J Trop Pediatr 2011; 58(4): 326–328.
6.
Scher M. Perinatal asphyxia: timing and mechanisms of injury in neonatal encephalopathy. Curr Neurol Neurosci Rep 2001; 1(2): 175–184.
7.
Valko M, Rhodes C, Moncol J, et al. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006; 160(1): 1–40.
8.
Uttara B, Singh AV, Zamboni P, et al. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 2009; 7(1): 65–74.
9.
Mayne ST. Antioxidant nutrients and chronic disease: use of biomarkers of exposure and oxidative stress status in epidemiologic research. J Nutr 2003; 133(3): 933S–940S.
10.
Gitto E, Reiter RJ, Karbownik M, et al. Respiratory distress syndrome in the newborn: role of oxidative stress. Intensive Care Med 2001; 27(7): 1116–1123.
11.
Qanungo S, Mukherjea M. Ontogenic profile of some antioxidants and lipid peroxidation in human placental and fetal tissues. Mol Cell Biochem 2000; 215(1–2): 11–19.
12.
Tyurin VA, Liu S-X, Tyurina YY, et al. Elevated levels of S-nitrosoalbumin in preeclampsia plasma. Circ Res 2001; 88(11): 1210–1215.
13.
Tamura T, Olin KL, Goldenberg RL, et al. Plasma extracellular superoxide dismutase activity in healthy pregnant women is not influenced by zinc supplementation. Biol Trace Elem Res 2001; 80(2): 107–113.
14.
Cikot RJ, Steegers-Theunissen RP, Thomas CM, et al. Longitudinal vitamin and homocysteine levels in normal pregnancy. Br J Nutr 2001; 85(1): 49–58.
15.
Watson A, Palmer M, Jauniaux E, et al. Variations in expression of copper/zinc superoxide dismutase in villous trophoblast of the human placenta with gestational age. Placenta 1997; 18(4): 295–299.
16.
Znamenskaia T. Role of antioxidant enzymes of the fetoplacental complex in neonatal adaptation to maternal diabetes mellitus. Ukr Biokhim Zh (1978) 1994; 66(2): 93–97.
17.
Raijmakers MT, Dechend R, Poston L. Oxidative stress and preeclampsia: rationale for antioxidant clinical trials. Hypertension 2004; 44(4): 374–380.
18.
Burton GJ, Jauniaux E. Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Investig 2004; 11(6): 342–352.
19.
Dizdar EA, Uras N, Oguz S, et al. Total antioxidant capacity and total oxidant status after surfactant treatment in preterm infants with respiratory distress syndrome. Ann Clin Biochem 2011; 48(5): 462–267.
20.
Ahmed AE-A, Abd-Elmawgood EA, Hassan MH. Circulating Protein Carbonyls, Antioxidant Enzymes and Related Trace Minerals among Preterms with Respiratory Distress Syndrome. J Clin Diagn Res 2017; 11(7): BC17.
21.
Pouya VT, Hashemy SI, Shoeibi A, et al. Serum Pro-Oxidant-Antioxidant Balance, Advanced Oxidized Protein Products (AOPP) and Protein Carbonyl in Patients with Stroke. Razavi Int J Med 2016; 4(2): e38203.
22.
Alamdari DH, Ghayour-Mobarhan M, Tavallaie S, et al. Prooxidant–antioxidant balance as a new risk factor in patients with angiographically defined coronary artery disease. Clin Biochem 2008; 41(6): 375–380.
23.
Boskabadi H, Moeini M, Tara F, et al. Determination of prooxidant–antioxidant balance during uncomplicated pregnancy using a rapid assay. J Med Biochem 2013; 32(3): 227–232.
24.
Alamdari DH, Paletas K, Pegiou T, et al. A novel assay for the evaluation of the prooxidant–antioxidant balance, before and after antioxidant vitamin administration in type II diabetes patients. Clin Biochem 2007; 40(3–4): 248–254.
25.
Verder H, Robertson B, Greisen G, et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. New Engl J Med 1994; 331(16): 1051–1055.
26.
Bhandari V, Maulik N, Kresch M. Hyperoxia causes an increase in antioxidant enzyme activity in adult and fetal rat type II pneumocytes. Lung 2000; 178(1): 53–60.
27.
Ikegami M, Kallapur S, Michna J, et al. Lung injury and surfactant metabolism after hyperventilation of premature lambs. Pediatr Res 2000; 47(3): 398.
28.
Davis JM, Auten RL, eds. Maturation of the antioxidant system and the effects on preterm birth. Semin Fetal Neonatal Med 2010; 15(4): 191–195.
29.
Georgeson GD, Szőny BJ, Streitman K, et al. Antioxidant enzyme activities are decreased in preterm infants and in neonates born via caesarean section. Eur J Obstet Gynecol Reprod Biol 2002; 103(2): 136–139.
30.
Little RE, Gladen BC. Levels of lipid peroxides in uncomplicated pregnancy: a review of the literature. Reprod Toxicol 1999; 13(5): 347–352.
31.
Chen X, Scholl TO. Oxidative stress: changes in pregnancy and with gestational diabetes mellitus. Curr Diabetes Rep 2005; 5(4): 282–288.
32.
Takehara Y, Yoshioka T, Sasaki J. Changes in the levels of lipoperoxide and antioxidant factors in human placenta during gestation. Acta Med Okayama 1990; 44(2): 103–111.
